Ameritas Investment Partners’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-596
| Closed | -$146K | – | 3062 |
|
|
2022
Q3 | $146K | Hold |
596
| – | – | 0.01% | 1243 |
|
|
2022
Q2 | $147K | Hold |
596
| – | – | 0.01% | 1251 |
|
|
2022
Q1 | $197K | Hold |
596
| – | – | 0.01% | 1195 |
|
|
2021
Q4 | $214K | Sell |
596
-61
| -9% | -$20.6K | 0.01% | 1195 |
|
|
2021
Q3 | $214K | Hold |
657
| – | – | 0.01% | 1153 |
|
|
2021
Q2 | $205K | Hold |
657
| – | – | 0.01% | 1232 |
|
|
2021
Q1 | $209K | Hold |
657
| – | – | 0.01% | 1180 |
|
|
2020
Q4 | $213K | Sell |
657
-65
| -9% | -$18K | 0.01% | 1107 |
|
|
2020
Q3 | $200K | Hold |
722
| – | – | 0.01% | 1031 |
|
|
2020
Q2 | $174K | Sell |
722
-78
| -10% | -$15.7K | 0.01% | 1079 |
|
|
2020
Q1 | $116K | Hold |
800
| – | – | 0.01% | 1188 |
|
|
2019
Q4 | $136K | Hold |
800
| – | – | 0.01% | 1322 |
|
|
2019
Q3 | $142K | Hold |
800
| – | – | 0.01% | 1254 |
|
|
2019
Q2 | $208K | Hold |
800
| – | – | 0.01% | 1039 |
|
|
2019
Q1 | $228K | Hold |
800
| – | – | 0.01% | 980 |
|
|
2018
Q4 | $260K | Hold |
800
| – | – | 0.01% | 860 |
|
|
2018
Q3 | $360K | Hold |
800
| – | – | 0.02% | 821 |
|
|
2018
Q2 | $327K | Sell |
800
-11,754
| -94% | -$4.26M | 0.02% | 839 |
|
|
2018
Q1 | $3.65M | Hold |
12,554
| – | – | 0.18% | 101 |
|
|
2017
Q4 | $2.35M | Buy |
12,554
+359
| +3% | +$67K | 0.11% | 207 |
|
|
2017
Q3 | $1.84M | Hold |
12,195
| – | – | 0.09% | 271 |
|
|
2017
Q2 | $1.75M | Buy |
12,195
+259
| +2% | +$34.8K | 0.08% | 276 |
|
|
2017
Q1 | $1.49M | Sell |
11,936
-170
| -1% | -$19.7K | 0.07% | 334 |
|
|
2016
Q4 | $1.36M | Buy |
12,106
+110
| +0.9% | +$12.7K | 0.07% | 373 |
|
|
2016
Q3 | $1.54M | Buy |
11,996
+5,779
| +93% | +$692K | 0.08% | 298 |
|
|
2016
Q2 | $679K | Sell |
6,217
-2,954
| -32% | -$294K | 0.04% | 458 |
|
|
2016
Q1 | $870K | Buy |
9,171
+5,950
| +185% | +$502K | 0.06% | 352 |
|
|
2015
Q4 | $291K | Hold |
3,221
| – | – | 0.02% | 810 |
|
|
2015
Q3 | $299K | Hold |
3,221
| – | – | 0.02% | 766 |
|
|
2015
Q2 | $212K | Sell |
3,221
-298
| -8% | -$19.8K | 0.01% | 948 |
|
|
2015
Q1 | $252K | Buy |
+3,519
| New | +$191K | 0.02% | 915 |
|
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Ameritas Investment Partners's ABMD Position: Q4 2022 in Review
Ameritas Investment Partners sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 596 shares — an estimated $146K sold.
Ameritas Investment Partners first reported a position in ABMD in Q1 2015 and held it in 31 quarters. The position peaked at $3.65M in Q1 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Ameritas Investment Partners reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Ameritas Investment Partners sold 596 Abiomed Inc shares in Q4 2022, an estimated $146K.
- Ameritas Investment Partners first reported a position in Abiomed Inc in Q1 2015 and held it in 31 quarters.
- Ameritas Investment Partners's Abiomed Inc position peaked at $3.65M in Q1 2018.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Ameritas Investment Partners's 13F filing for Q4 2022, filed 13 Feb 2023.